Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday

Cingulate CING	0.00	0.00%
CleanSpark CLSK	0.00	0.00%
Guidewire Software GWRE	0.00	0.00%
Hyperion DeFi HYPD	0.00	0.00%
Insmed INSM	0.00	0.00%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

BTIG raised the price target for Oncology Institute Inc (NASDAQ:TOI) from $7 to $8. Piper Sandler analyst Clarke Jeffries maintained a Neutral rating. Oncology Institute shares closed at $4.87 on Friday. See how other analysts view this stock.
JP Morgan increased Victorias Secret & Co. (NYSE:VSXY) price target from $77 to $88. JP Morgan analyst Matthew Boss maintained an Overweight rating. Victorias Secret shares closed at $74.58 on Friday. See how other analysts view this stock.
DA Davidson cut price target for Guidewire Software, Inc. (NYSE:GWRE) from $246 to $222. DA Davidson analyst Peter Heckmann maintained a Buy rating. Guidewire Software shares closed at $136.08 on Friday. See how other analysts view this stock.
Chardan Capital raised the price target for CleanSpark, Inc. (NYSE:CLSK) from $16 to $19. Chardan Capital analyst James McIlree maintained a Buy rating. CleanSpark shares closed at $15.59 on Friday. See how other analysts view this stock.
Rosenblatt raised Navan, Inc. (NASDAQ:NAVN) price target from $20 to $24. Rosenblatt analyst Blair Abernethy maintained a Buy rating. Navan shares closed at $21.20 on Friday. See how other analysts view this stock.
Needham raised Sportradar Group AG (NASDAQ:SRAD) price target from $19 to $23. Needham analyst Bernie McTernan maintained a Buy rating. Sportradar shares closed at $13.90 on Friday. See how other analysts view this stock.
Ascendiant Capital cut Plus Therapeutics, Inc. (NASDAQ:PSTV) price target from $65 to $57. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Plus Therapeutics shares closed at $5.41 on Friday. See how other analysts view this stock.
Chardan Capital cut the price target for Hyperion DeFi, Inc. (NASDAQ:HYPD) from $8.25 to $7.3. Chardan Capital analyst James McIlree maintained a Buy rating. Hyperion DeFi shares closed at $3.50 on Friday. See how other analysts view this stock.
JP Morgan lowered Insmed Incorporated (NASDAQ:INSM) price target from $180 to $179. JP Morgan analyst Jessica Fye maintained an Overweight rating. Insmed shares closed at $94.22 on Friday. See how other analysts view this stock.
Ascendiant Capital cut Cingulate Inc. (NASDAQ:CING) price target from $55 to $52. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Cingulate shares closed at $4.4950 on Friday. See how other analysts view this stock.

Considering buying INSM stock? Here’s what analysts think:

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.